ArticleHuman vaccines & immunotherapeutics2022

Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China.

Tao-Hsin Tung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.